Risultati della ricerca - Norbert Gattermann

Raffina i risultati
  1. 1
    Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload

    Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload di Norbert Gattermann

    Pubblicazione 2008
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    The Treatment of Secondary Hemochromatosis

    The Treatment of Secondary Hemochromatosis di Norbert Gattermann

    Pubblicazione 2009
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    Iron overload in myelodysplastic syndromes (MDS)

    Iron overload in myelodysplastic syndromes (MDS) di Norbert Gattermann

    Pubblicazione 2017
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Valproic acid for the treatment of myeloid malignancies

    Valproic acid for the treatment of myeloid malignancies di Andrea Kuendgen, Norbert Gattermann

    Pubblicazione 2007
    Testo Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  5. 5
    Iron overload in MDS—pathophysiology, diagnosis, and complications

    Iron overload in MDS—pathophysiology, diagnosis, and complications di Norbert Gattermann, Eliezer A. Rachmilewitz

    Pubblicazione 2010
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  6. 6
    Myelodysplastic Syndromes

    Myelodysplastic Syndromes di Peter L. Greenberg, Neal S. Young, Norbert Gattermann

    Pubblicazione 2002
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  7. 7
    Myelodysplastic Syndromes

    Myelodysplastic Syndromes di Ulrich Germing, Guido Kobbe, Rainer Haas, Norbert Gattermann

    Pubblicazione 2013
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  8. 8
    The evaluation of iron deficiency and iron overload

    The evaluation of iron deficiency and iron overload di Norbert Gattermann, Martina U. Muckenthaler, Andreas E. Kulozik, Georgia Metzgeroth, Jan Hastka

    Pubblicazione 2021
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  9. 9
    Myelodysplastic Syndromes in Patients Younger Than Age 50

    Myelodysplastic Syndromes in Patients Younger Than Age 50 di Andrea Kuendgen, Corinna Strupp, Manuel Aivado, Barbara Hildebrandt, Rainer Haas, Norbert Gattermann, Ulrich Germing

    Pubblicazione 2006
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients With Acquired Idiopathic Sideroblastic Anemia

    Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients With Acquired Idiopathic Sideroblastic Anemia di Norbert Gattermann, Stefan Retzlaff, Yanling Wang, Götz Hofhaus, Jürgen J. Heinisch, Carlo Aul, Wolfgang Schneider

    Pubblicazione 1997
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

    High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifia... di Norbert Gattermann, Johan Billiet, Ralf Kronenwett, E. Zipperer, Ulrich Germing, Friedel Nollet, A. Criel, Dominik Selleslag

    Pubblicazione 2007
    Testo Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  12. 12
    Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

    Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid di Andrea Kuendgen, Corinna Strupp, Manuel Aivado, A. Bernhardt, Barbara Hildebrandt, Rainer Haas, Ulrich Germing, Norbert Gattermann

    Pubblicazione 2004
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

    The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome di E. Zipperer, D. Pelz, Kathrin Nachtkamp, A. Kuendgen, C. Strupp, Norbert Gattermann, Rainer Haas, Ulrich Germing

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes

    Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes di Sabine Knipp, Barbara Hildebrand, Andrea Kündgen, Aristoteles Giagounidis, Guido Kobbe, Rainer Haas, Carlo Aul, Norbert Gattermann, Ulrich Germing

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes

    Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes di Judith Neukirchen, Sabine Blum, Andrea Kuendgen, Corinna Strupp, Manuel Aivado, Rainer Haas, Carlo Aul, Norbert Gattermann, Ulrich Germing

    Pubblicazione 2009
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Chronic myelomonocytic leukemia in the light of the WHO proposals

    Chronic myelomonocytic leukemia in the light of the WHO proposals di Ulrich Germing, C. Strupp, S. Knipp, A. Kuendgen, Aristoteles Giagounidis, B. Hildebrandt, C. Aul, R Haas, Norbert Gattermann, John M. Bennett

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia

    The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia di Andrea Kuendgen, Mathias Schmid, Richard F. Schlenk, Sabine Knipp, Barbara Hildebrandt, Christian Steidl, Ulrich Germing, Rainer Haas, Hartmut Döhner, Norbert Gattermann

    Pubblicazione 2005
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes

    Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes di Lewis R. Silverman, Pierre Fenaux, Ghulam J. Mufti, Valeria Santini, Eva Hellström‐Lindberg, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells

    Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells di Ulrich Steidl, Ralf Kronenwett, Ulrich‐Peter Rohr, Roland Fenk, Slawomir Kliszewski, Christian Maercker, Peter Neubert, Manuel Aivado, J. H. Koch, Olga Modlich, Hans Bojar, Norbert Gattermann, Rainer Haas

    Pubblicazione 2002
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients

    High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients di Jeffrey W. Tyner, Heidi S. Erickson, Michael W. Deininger, Stephanie G. Willis, Christopher A. Eide, Ross L. Levine, Michael C. Heinrich, Norbert Gattermann, D. Gary Gilliland, Brian J. Druker, Marc Loriaux

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: